Discover 3,132 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,132
Active & Responsive
Sentinel Node Biopsy in Endometrial Cancer
for
Endometrial Cancer Stage I, Sentinel Lymph Node, Surgery
Location: Houston TX
Sponsor: Queensland Centre for Gynaecological Cancer
Sex: Female
Age: 18+
Code: NCT04073706
Phase 3, Recruiting
Active & Responsive
Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes
for
End Stage Liver Disease
Location: Houston TX
Sponsor: LyGenesis, Inc.
Sex: All
Age: 18 - 70
Code: NCT04496479
Phase 2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: Houston TX, Dallas TX, Nashville TN, Skokie IL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate the Safety and Effect of AVB-101, a Gene Therapy Product, in Subjects With a Genetic Sub-type of Frontotemporal Dementia (FTD-GRN)
An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)
for
Dilated Cardiomyopathy (DCM),
Location: Houston TX, Kansas City MO, Miami FL, New York NY,
Sponsor: Affinia Therapeutics
Sex: All
Age: 18 - 70
Code: NCT07426419
Phase 1, Phase 2, Recruiting
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Houston TX, Oklahoma City OK, Westwood KS, St Louis MO,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
for
Cancer, PDAC - Pancreatic Ductal Adenocarcinoma,
Location: Houston TX, San Antonio TX, Nashville TN, St Louis MO,
Sponsor: Alterome Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06835569
Phase 1, Recruiting
Active & Responsive
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
for
Chronic Kidney Diseases, End Stage Renal Disease,
Location: Houston TX, Sugar Land TX, Austin TX, Mission TX,
Sponsor: VenoStent
Sex: All
Age: 18+
Code: NCT06001827
Recruiting
Active & Responsive
Janus II Feasibility
for
Sleep Apnea
Location: Houston TX, Columbus OH, Scottsdale AZ, Wyoming MI
Sponsor: Zoll Medical Corporation
Sex: All
Age: 22+
Code: NCT06556693
Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Houston TX, Galveston TX, Little Rock AR,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
for
Relapsed or Refractory Multiple Myeloma
Location: Houston TX, Duarte CA
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07681596
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
for
Relapsed Refractory Multiple Myeloma
Location: Houston TX, Austin TX, Nashville TN, Atlanta GA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07391657
Phase 3, Recruiting
Active & Responsive
ALXN2350 in Adult Participants With BAG3-Associated Dilated Cardiomyopathy
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma
for
Osteogenic Sarcoma Recurrent
Location: Houston TX, Hackensack NJ
Sponsor: Hackensack Meridian Health
Sex: All
Age: 8 - 30
Code: NCT05726383
Phase 2, Recruiting
Active & Responsive
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention